Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of 2,3,7,8-Tetrachlorodibenzo-p-dioxin 10157-G

 

CASRN: 1746-01-6

Formula: C12-H4-Cl4-O2

Synonyms/Common Names

  • TCDD
  • 2,3,7,8-Tetrachlorodibenzo(B,E)(1,4)dioxin (9CI)
  • 2,3,7,8-Tetrachlorodibenzo-1,4-dioxin

Short-Term Toxicity

  • 14-Day (Gavage)  (C03714A)  Completed 
    • Rats: Osborne Mendel; Mice: B6C3F1
  • 14-Day (Topical Application)  (C03714B)  Completed 
    • Mice: Swiss Webster
  • 13-Week (Gavage)  (C03714A)  Completed 
    • Rats: Osborne Mendel; Mice: B6C3F1
    • Dose: R: 0, .5, 8, M: 0, 1, 20 UG/KG/WK/10 PER GROUP.
  • 13 weeks (Topical Application)  (C03714B)  Completed 
    • Mice: Swiss Webster
    • Dose: 0, .005, 10 UG/10 PER GROUP.

Long-Term Carcinogenicity

  • 2-Year (Gavage)  (C03714A)  Completed 
    • TR-209 (NIH Number: 82-1765)  (Peer Review Approval 06/27/1980A )
      Carcinogenesis Bioassay of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (CASRN 1746-01-6) in Osborne-Mendel Rats and B6C3F1 Mice (Gavage Study)
    • Rats: Osborne Mendel; Mice: B6C3F1
    • Carcinogenesis Results
      • Male Rats Positive 
      • Female Rats Positive 
      • Male Mice Positive 
      • Female Mice Positive 
    • Dose: R&MM: 0, .01, .05, .5 UG/KG/WK/50 PER GROUP FM: 0, .04, .2, 2.0 UG/KG/WK/50 PER GROUP.
  • 2 years (Topical Application)  (C03714B)  Completed 
    • TR-201 (NIH Number: 82-1757)  (Peer Review Approval 06/27/1980A )
      Carcinogenesis Bioassay of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (CASRN 1746-01-6) in Swiss-Webster Mice (Dermal Study)
    • Mice: Swiss Webster
    • Carcinogenesis Results
      • Male Mice Equivocal 
      • Female Mice Positive 
    • Dose: FM: 0, .005, MM: 0, .001 UG/60 PER GROUP.

Special Studies

  • Absorption Disposition Metabolism Elimination (Topical Application)  (S0680)  Completed 
    • Citation: Brewster DW, Banks YB, Clark AM, Birnbaum LS. Comparative dermal absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin and three polychlorinated dibenzofurans. Toxicol Appl Pharmacol. 1989 Jan;97(1):156-66.Pubmed Abstract
    • Male Rats: F344/N
  • Absorption Disposition Metabolism Elimination (Topical Application)  (S0684)  Completed 
    • Citation: Banks YB, Brewster DW, Birnbaum LS. Age-related changes in dermal absorption of 2,3,7, 8-tetrachlorodibenzo-p-dioxin and 2,3,4,7,8-pentachlorodibenzofuran. Fundam Appl Toxicol. 1990 Jul;15(1):163-73.Pubmed Abstract
    • Male Rats: F344/N
  • Absorption Disposition Metabolism Elimination (Topical Application)  (S0685)  Completed 
    • Citation: Banks YB, Birnbaum LS. Absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) after low dose dermal exposure. Toxicol Appl Pharmacol. 1991 Feb;107(2):302-10. Pubmed Abstract
    • Male Rats: F344/N
    • Dose: 1 nmol/kg.
  • Absorption Disposition Metabolism Elimination  (S0691)  Completed 
    • Citation: Hébert CD, Birnbaum LS. The influence of aging on intestinal absorption of TCDD in rats. Toxicol Lett. 1987 Jun;37(1):47-55.Pubmed Abstract
    • Male Rats: F344/N
  • Cell Proliferation  (S0692)  Completed 
    • Citation: Hébert CD, Cao QL, Birnbaum LS. Inhibition of high-density growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Carcinogenesis. 1990 Aug;11(8):1335-42. Pubmed Abstract
    • Citation: Hébert CD, Cao QL, Birnbaum LS. Role of transforming growth factor beta in the proliferative effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on human squamous carcinoma cells. Cancer Res. 1990 Nov 15;50(22):7190-7.Pubmed Abstract
    • Human (Cell Lines)
  • Mechanisms (Gavage)  (S0681)  Completed 
    • Citation: Harris MW, Uriah LC, Birnbaum LS. Acute toxicity of perfluorodecanoic acid in C57BL/6 mice differs from 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1989 Nov;13(4):723-36.Pubmed Abstract
    • Female Mice: C57BL/6
    • Dose: 0 to 320 mg/kg.
  • Mechanisms (Gavage)  (S0682)  Completed 
    • Citation: Abbott BD, Birnbaum LS. Cellular alterations and enhanced induction of cleft palate after coadministration of retinoic acid and TCDD. Toxicol Appl Pharmacol. 1989 Jun 15;99(2):287-301.Pubmed Abstract
    • Male and Female Mice: C57BL/6
  • Mechanisms (Gavage)  (S0683)  Completed 
    • Citation: Brewster DW, Birnbaum LS. The biochemical toxicity of perfluorodecanoic acid in the mouse is different from that of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 1989 Jul;99(3):544-54.Pubmed Abstract
    • Female Mice: C57BL/6
    • Dose: Ahb/b strain 0, 40, 80, 100, 120, 160 mk/kg: Ahb/d strain 0, 40, 80, 160 mg/kg: Ahd/d strain 0, 40, 80, 120 mk/kg.
  • Mechanisms (Topical Application)  (S0690)  Completed 
    • Citation: Stohs SJ, Abbott BD, Lin FH, Birnbaum LS. Induction of ethoxyresorufin-O-deethylase and inhibition of glucocorticoid receptor binding in skin and liver of haired and hairless HRS/J mice by topically applied 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology. 1990 Dec 17;65(1-2):123-36.Pubmed Abstract
    • Female Mice
    • Dose: 12µg/kg.
  • Toxicokinetic Study (Gavage)  (K01807)  Completed 
    • Female Rats: Sprague Dawley
  • Toxicokinetic Study (Gavage)  (S0621)  Completed 
    • Male and Female Rats: Sprague Dawley
    • Dose: FEMALE RATS: 0, 1, 3, 10, 30, 100 NG/KG MALE RATS TO BE USED AS SENTINELS..

Genetic Toxicology

  • Chromosome Aberrations  (163229)  Completed 
    • Mice
    •  Negative 
  • Drosophila  (601370)  Completed 
    • Citation: Zimmering, S., Mason, J.M., Valencia, R., and Woodruff, R.C. Chemical mutagenesis testing in Drosophila. II. Results of 20 coded compounds tested for the National Toxicology Program. Environ. Mutagen. Vol. 7 (1985) 87-100
    • Reciprocal Translocation/Sex-Linked Recessive Lethal Negative 
  • In Vitro Cytogenetics (CA/SCE)  (764904)  Completed 
    • Citation: Galloway, S., Armstrong, M., Reuben, C., Colman, S., Brown, B., Cannon, C., Bloom, A., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., Margolin, B., Resnick, M., Anderson, B., and Zeiger, E. Chromosome aberration and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ. Molec. Mutagen. Vol. 10 (Suppl 10) (1987) 1-176
    • Sister Chromatid Exchange Negative 
    • Chromosome Aberrations Negative 
  • Mouse Lymphoma  (056688)  Completed 
    • Citation: McGregor, D., Brown, A., Howgate, S., McBride, D., Riach, C., and Caspary, W. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. IV: 27 coded chemicals. Environ. Molec. Mutagen. Vol. 17 (1991) 196-219
    • Mice
    •  Negative 
  • Salmonella  (904370)  Completed 
    • Citation: Mortelmans, K., Haworth, S., Speck, W., and Zeiger, E. Mutagenicity testing of Agent Orange components and related chemicals Toxicology and Applied Pharmacology Vol. 75 (1984) 137-146
    •  Negative 
  • Sister Chromatid Exchanges  (163229)  Completed 
    • Mice
    • Sister Chromatid  Not a Valid Test 

Organ Systems Toxicity

  • single dose Immunotoxicity (Gavage)  (I10157)  Completed 
    • Female Mice: B6C3F1
    • Dose: 0, 0.1, 0.3, 0.5, 1, or 3 ug/kg.
  • 14 days Immunotoxicity (Gavage)  (IMM95007)  Completed 
    • Female Mice: B6C3F1
    • Dose: 0.86 ug/kg.
  • Teratology Pilot Studies (Gavage & Intraperitoneal Injection)  (TRP92026)  Completed 
    • Male and Female Mice: C57BL/6
    • Dose: 0, 9, 12, OR 15 UG/KG + 10 MG/KG PYRAN.
  • Teratology Pilot Studies (Gavage & Intraperitoneal Injection)  (TRP92061)  Completed 
    • Male and Female Mice: C57BL/6
    • Dose: 0, 12, OR 15 UG/KG + PYRAN 0, 10, 50, OR 100 MG/KG.
  • Teratology Pilot Studies (Gavage & Intraperitoneal Injection)  (TRP92063)  Completed 
    • Male and Female Mice: C57BL/6
    • Dose: 0, 6, 12, OR 24 UG/KG TCDD; PYRAN 0, 10 MG/KG.

Toxicogenomics

  • Microarray Analysis  (T10157)  Completed